The pharmaceutical landscape for blood sugar is evolving, and transdermal GLP-1 delivery systems represent a promising development. Unlike shots, this approach offers a simpler way to administer GLP-1 therapies. https://roybgsh533727.liberty-blog.com/41265640/glp-1-patches-a-new-approach-to-diabetes-management